Antirobe Vet. 25 mg kapsler, hårde Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

antirobe vet. 25 mg kapsler, hårde

zoetis animal health aps - clindamycinhydrochlorid - kapsler, hårde - 25 mg

Antirobe Vet. 75 mg kapsler, hårde Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

antirobe vet. 75 mg kapsler, hårde

zoetis animal health aps - clindamycinhydrochlorid - kapsler, hårde - 75 mg

Dalacin C 150 mg kapsler, hårde Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

dalacin c 150 mg kapsler, hårde

europharma.dk aps - clindamycinhydrochlorid - kapsler, hårde - 150 mg

Givix Vet. 25 mg/ml oral opløsning Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

givix vet. 25 mg/ml oral opløsning

ceva santé animale - clindamycinhydrochlorid - oral opløsning - 25 mg/ml

Clindabactin 55 mg tyggetabletter Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

clindabactin 55 mg tyggetabletter

dechra regulatory b.v. - clindamycinhydrochlorid - tyggetabletter - 55 mg

Shingrix Evropská unie - dánština - EMA (European Medicines Agency)

shingrix

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - vacciner - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. brug af shingrix bør være i overensstemmelse med de officielle anbefalinger.

Arexvy Evropská unie - dánština - EMA (European Medicines Agency)

arexvy

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - respiratoriske syncytiale virusinfektioner - vacciner - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. brug af denne vaccine bør være i overensstemmelse med de officielle anbefalinger.

Leqvio Evropská unie - dánština - EMA (European Medicines Agency)

leqvio

novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - lipid modificerende midler - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.